Reneo Pharmaceuticals, Inc. (RPHM)
NASDAQ: RPHM · IEX Real-Time Price · USD
1.480
+0.010 (0.68%)
At close: Jul 19, 2024, 4:30 PM
1.430
-0.050 (-3.38%)
Pre-market: Jul 22, 2024, 6:10 AM EDT
Reneo Pharmaceuticals Market Cap
Reneo Pharmaceuticals has a market cap or net worth of $49.46 million as of July 22, 2024. Its market cap has decreased by -78.35% in one year.
Market Cap
49.46M
Enterprise Value
-32.47M
1-Year Change
-78.35%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since the IPO on April 9, 2021, Reneo Pharmaceuticals's market cap has decreased from $363.16M to $49.46M, a decrease of -86.38%. That is a compound annual growth rate of -45.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 49.50M | -7.13% |
| Dec 29, 2023 | 53.30M | -6.82% |
| Dec 30, 2022 | 57.20M | -72.61% |
| Dec 31, 2021 | 208.80M | -42.50% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocuphire Pharma | 51.59M |
| Aerovate Therapeutics | 51.30M |
| Inotiv | 50.64M |
| Estrella Immunopharma | 49.84M |
| vTv Therapeutics | 49.63M |
| DURECT | 49.35M |
| Modular Medical | 48.81M |
| Bionano Genomics | 48.13M |